Quantifying Consciousness

Overall brain metabolic rate can distinguish between pathological states of human consciousness, a study shows.

Written byTanya Lewis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

PET imaging of brain glucose metabolismSTENDERS ET AL.Differentiating states of consciousness in brain-injured patients is a major challenge for clinicians. Researchers from the University of Copenhagen, Denmark, and their colleagues recently used positron emission tomography (PET) to measure the metabolism of glucose in the brains of 131 patients, finding that 42 percent of normal cortical function is the minimum amount of energy required for conscious awareness. The findings provide “a simple and objective metabolic marker” of consciousness, the authors wrote in their study, published today (May 26) in Current Biology.

“[The study authors] distinguished a strong physical measurement of two different states of lowered consciousness beautifully, with excellent data,” Robert Shulman of Yale University, who reviewed the study, told The Scientist. “They did this by measuring the cerebral metabolic rate of glucose consumption using PET, [which is] a strong, reliable measurement,” he added.

Previous studies have shown that brain glucose metabolism declines when consciousness is lost, but researchers did not have a quantitative measure for distinguishing between disorders of consciousness—such as coma, minimally conscious state (MCS), and the more severe unresponsive wakefulness syndrome (UWS). Ron Kupers of the University of Copenhagen and colleagues last year showed that MCS and UWS are associated with brain metabolic levels that are approximately half those of healthy adults in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies